Miplyffa Capsule
Product Images NDC 72542-124

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Miplyffa (NDC 72542-124). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Acer Therapeutics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Mip00 0001 01)

FDA Label Image

Figure 1 (Mip00 0001 02)

Mean change from baseline in RIDNPCCSS over time is being evaluated for two groups - one group receiving MIPLYFFA with miglustat and the other group receiving Placebo with miglustat. The data shows the progression of the mean change in RIDNPCCSS scores over a span of 12 months for both groups.*

FDA Label Image

Figure A (Mip00 0001 03)

FDA Label Image

Figure B (Mip00 0001 04)

FDA Label Image

Figure C (Mip00 0001 05)

FDA Label Image

Figure D (Mip00 0001 06)

FDA Label Image

Figure E (Mip00 0001 07)

FDA Label Image

Figure F (Mip00 0001 08)

FDA Label Image

Figure G (Mip00 0001 09)

FDA Label Image

Figure H (Mip00 0001 10)

FDA Label Image

Figure I (Mip00 0001 11)

FDA Label Image

Figure J (Mip00 0001 12)

FDA Label Image

Figure K (Mip00 0001 13)

FDA Label Image

Principal Display Panel – 47 mg Carton Label (Mip00 0001 14)

This is a product label for "IMPLIFYFFA" capsules (arimoclomol) containing 90 capsules for oral use. Each capsule contains 47 mg of arimoclomol equivalent to 75 mg of arimoclomol citrate. The recommended dosage is specified in the prescribing information. The capsules should be stored between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). It is advised to store the capsules in the original container, protect from light, and keep out of reach of children. The product is manufactured for Zevra Therapeutics, Inc. in Celebration, FL, USA.*

FDA Label Image

Principal Display Panel – 62 mg Carton Label (Mip00 0001 15)

This text provides information about arimoclomol capsules in 62mg strength and a package containing 90 capsules for oral use. It includes the recommended dosage, storage instructions, and manufacturer details. The capsules contain arimoclomol citrate and are for prescription use only.*

FDA Label Image

Principal Display Panel – 93 mg Carton Label (Mip00 0001 16)

This text provides information about a prescription medication called "MIPLYFFA" (arimoclomol) capsules. It includes details such as the recommended dosage, storage instructions, active ingredients, and package size. The medication is indicated for oral use and is available in a container with a child-resistant package. It is important to refer to the prescribing information before use.*

FDA Label Image

Principal Display Panel – 124 mg Carton Label (Mip00 0001 17)

This text appears to be a description of a medication called "IMIPLYFFA" (arimoclomol) capsules. It includes information such as the dosage, active ingredients, storage instructions, manufacturer details, and the fact that it is for oral use. The recommended dosage and storage conditions are also provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.